Adalimumab Adalimab SC 40mg Injection is a medicine used to treat various inflammatory and autoimmune conditions, such as rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis. It contains 40 mg of adalimumab, a monoclonal antibody that works by inhibiting tumor necrosis factor-alpha (TNF-α), a protein that triggers inflammation in the body. By blocking TNF-α, it helps reduce inflammation, pain, and tissue damage. This Adalimumab Adalimab SC 40mg Injection is administered as a subcutaneous injection, typically given every two weeks, depending on the condition being treated. As with other TNF inhibitors, it may increase the risk of infections and other side effects, requiring monitoring during treatment.
